Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04221035
Title High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN) (HR-NBL2)
Acronym HR-NBL2
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Gustave Roussy, Cancer Campus, Grand Paris
Age Groups: child | adult
Covered Countries NLD | ITA | GBR | FRA | ESP | DEU | BEL | AUS

No variant requirements are available.